- Cipla Q2 Results: PAT rises 15% YoY to Rs 1,303 crore, beats estimates The Economic Times
- Cipla stock in focus after Q2 PAT beats estimates. Should you buy, sell or hold? The Economic Times
- Multiple near-term challenges may hijack Cipla’s growth trajectory Moneycontrol
- Cipla’s Kamil Hamied back on board; Q2 net profit rises 15% to ₹1,303 crore Mint
- Cipla share price: Cipla faces challenges of slow growth, drug launch; analysts slash target Business Standard
Cipla Q2 Results: PAT rises 15% YoY to Rs 1,303 crore, beats estimates The Economic TimesCipla stock in focus after Q2 PAT beats estimates. Should you buy, sell or hold? The Economic TimesMultiple near-term challenges may hijack Cipla’s growth trajectory MoneycontrolCipla’s Kamil Hamied back on board; Q2 net profit rises 15% to ₹1,303 crore MintCipla share price: Cipla faces challenges of slow growth, drug launch; analysts slash target Business Standard Top stories – Google News